Highlights 4basebio PLC

Equities

4BB

GB00BMCLYF79

Delayed London S.E. Other stock markets 11:48:57 14/05/2024 BST			5-day change	1st Jan Change
1,390 ^GBX	+13.93%		+28.70%	+104.41%

04-10	4basebio to supply synthetic DNA for mRNA vaccine program	AN
04-10	4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

4basebio to supply synthetic DNA for mRNA vaccine program	04-10	AN
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	04-10	CI
4basebio updates markets on "key milestone" with client	03-21	AN
Alpha Real Trust says in "robust" financial shape	03-01	AN
4basebio wins DNA supply contract to support RNA therapies	03-01	AN
4basebio Wins Synthetic DNA Supply Tender from CPI	03-01	MT
4basebio interim loss widens as research costs increase	21/09/23	AN
4basebio PLC Reports Earnings Results for the Half Year Ended June 30, 2023	21/09/23	CI
4basebio PLC Receives A Grant from the Bill & Melinda Gates Foundation to Advance the Development Program of Thermostable Nucleic Acid Based Vaccines	01/08/23	CI
4basebio PLC and Neomatrix Announce Product Supply Agreement	25/05/23	CI
4basebio PLC Reports Earnings Results for the Full Year Ended December 31, 2022	11/05/23	CI
4basebio PLC Announces Further Expansion of Its UK Facilities	03/04/23	CI
4basebio PLC Reports Earnings Results for the Half Year Ended June 30, 2022	30/09/22	CI
4basebio Teams Up With Universities to Research Neurofibromatosis Treatment	10/06/22	MT
4basebio PLC Announces Collaboration with University of Alabama and Teesside University	10/06/22	CI
4basebio PLC Reports Earnings Results for the Full Year Ended December 31, 2021	09/05/22	CI
4basebio PLC Announces Joint Development Agreement with Heqet Therapeutics	27/04/22	CI
4basebio PLC Announces the Expansion of its Synthetic DNA Product Offering	23/03/22	CI
4basebio Completes First Phase Of Synthetic DNA Business Development	15/02/22	MT
4basebio Unit Partners With eTheRNA To Study Linear DNA For mRNA Production	18/01/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights 4basebio PLC

Equities

4BB

GB00BMCLYF79

Highlights

Filters